Acylated piperidine derivatives as melanocortin-4 receptor agonists

Details for Australian Patent Application No. 2002250343 (hide)

International Classifications

Event Publications

6 March 2003 Application Open to Public Inspection

Published as AU-B-2002250343

25 May 2006 Application Accepted

Published as AU-B-2002250343

21 September 2006 Standard Patent Sealed

21 January 2010 Amendment Made

The nature of the amendment is: Amend patentee name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.

22 September 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.